You searched for "Prostate biopsy"

150 results found

40ml Syringes of Sterile Ultrasound Gel – Perfect for Prostate Biopsy

Say goodbye to the hassle of filling syringes with ultrasound gel during prostate biopsies. Our 40ml syringes come pre-filled with sterile, high-quality ultrasound gel, fully CE marked and compliant with NHS Infection Control regulations for your safety and peace of...

Increasing PSA after negative prostate biopsy - solving the clinical puzzle

There are standard guidelines for first transrectal ultrasonography (TRUS) guided biopsy in a patient presenting with elevated prostate-specific antigen (PSA) or suspicious digital rectal examination (DRE) findings. Patients are generally warned before a TRUS biopsy in respect of a false...

ESU-ESUI Masterclass on Prostate Biopsy

Aqua Medical: LATP Prostate Biopsy with Perino-Flex

Join renowned urologist Mr Ahmed Ali & Colleagues for an intensive hands-on LATP (Local Anesthesia Transperineal) Training Course featuring the groundbreaking Pernio-Flex, the world’s first prostate biopsy guide with angulation. Designed for urology professionals eager to enhance biopsy precision and patient comfort, this course covers every aspect of LATP technique using Pernio-Flex’s innovative design, which enables precise angulation for improved accuracy and accessibility

Fusion Bx 2.0 targeted prostate biopsy solution receives CE Mark

Focal Healthcare, an innovator of image-guided prostate cancer technology, has received CE Mark for its Fusion BxTM 2.0 prostate fusion biopsy solution.

The survival impact of neoadjuvant hormonal therapy before radical prostatectomy

There is increasing evidence for the role of radical prostatectomy in select patients with T3-T4 prostate cancer (as part of multimodal therapy). This retrospective multicentre study explored the benefit of neoadjuvant hormonal therapy before radical prostatectomy specifically in patients with...

Has laparoscopic radical prostatectomy had its day?

Over recent years there has been a massive uptake in robotic surgery particularly for robot-assisted prostatectomy. The drive for this has been patient and physician led with little in the way of prospective randomised trials showing benefits over established operative...

Dilemma of second primary tumour

Long-term survival in localised prostate cancer (CaP) can be achieved with treatment by either radical prostatectomy (RP) or external beam radiotherapy (EBRT). The development of second primary tumour is poorly understood in such cases. This retrospective study included 84,397 cases...

Impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomy

The functional side-effects of both radical prostatectomy and radiotherapy for prostate cancer are well known. The aim of this study was to evaluate if there was a significant worsening in recovery of urinary continence in those undergoing radical prostatectomy followed...

Ureteric injury rates during robot assisted radical prostatectomy

Jhaveri et al. and colleagues have produced a timely report on the incidence of ureteric injuries during robot assisted radical prostatectomy. They reviewed the complications of 6442 consecutive patients treated with robot assisted prostatectomy at the same institution by one...

RSM (Royal Society of Medicine) Complexity and Complications: Navigating Advanced Prostate Cancer

This year’s RSM Cancer Day will focus on the evolving management of prostate cancer. With emerging evidence supporting radical prostatectomy in oligometastatic disease, the programme will examine patient selection, treatment strategies, and the latest advances for managing advanced-stage cases.

Robot assisted laparoscopic prostatectomy versus open retropubic prostatectomy – complication and readmission rates

Readmission rates in postoperative patients are an important health economic and clinical challenge faced in the modern NHS, with financial levies attached. In America since 2013, hospitals have been faced with ‘readmission penalties’ deducted from Medicare reimbursements. This was the...